動物ワクチンと抗菌剤耐性:未充分利用のツール
Javier Yugueros-Marcos1, Floriane Etienne2
1Department of Antimicrobial Resistance and Veterinary Products, World Organisation for Animal Health, 75017 Paris, France.
まとめ
動物のワクチン接種は,病気の予防と抗生物質の使用の削減に不可欠であり,動物と公衆の健康の両方に利益をもたらします. ワクチンのアクセスと資金調達における課題を克服することは,抗菌剤耐性との闘いに不可欠です.
科学分野:
- 獣医医学 獣医医学は,獣医医学というものです.
- 公衆衛生は公衆衛生である.
- 感染症のコントロール・コントロール
背景:
- 動物のワクチン接種は,病気の予防と制御における成功の長い歴史を持っています.
- ワクチンは,抗生物質,抗寄生剤,抗ウイルス剤を含む抗菌剤への依存を軽減します.
- 動物のワクチン接種は,公衆衛生に,特に動物性感染症に寄与する.
研究 の 目的:
- 疾病予防と抗菌薬管理における動物ワクチン接種の利点を強調する.
- 動物ワクチンの利用可能性,アクセス,普及を妨げている課題を特定する.
- 動物ワクチンの研究,開発,実施を支援するための革新的な戦略を提唱する.
主な方法:
- この記事は,既存の知識と専門家の意見に基づいたレビューと政策の議論です.
- それは,動物ワクチンの有効性,安全性,および経済的側面に関する情報を合成します.
- ワクチンの開発,規制,導入の障壁を分析しています.
主要な成果:
- 動物ワクチンには大きな利点がありますが,安全性問題,規制上の障害,資金不足などの課題に直面しています.
- 限られた費用対効果データと商業的利益は,ワクチンの研究開発を妨げています.
- 現在のシステムには信頼と効率的な規制プロセスがなく,ワクチン接種キャンペーンを妨げています.
結論:
- 抗菌剤耐性に対処するために,革新的で,分野を超えたコラボレーションと新しい金融モデルが必要です.
- 公私パートナーシップの奨励は,動物保健と公衆衛生の進歩に不可欠です.
- 動物ワクチン研究への投資の増加とアクセスの改善は,世界保健安全保障にとって不可欠です.
さらに関連する動画
関連する概念動画
Biological Methods for Microbial Control
938
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
938
Microorganisms in Medicine and Therapeutics
1.2K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.2K
Antibiotic Selection
60.4K
Overview
60.4K
Development of Antibiotic Resistance
1.6K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.6K
Antimicrobial Effectiveness
1.1K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.1K
Antimicrobial Proteins
14.7K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.7K


